Literature DB >> 9813149

Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.

S Kawakami1, F Yamashita, M Nishikawa, Y Takakura, M Hashida.   

Abstract

We synthesized three novel galactosylated cholesterol derivatives, cholesten-5-yloxy-N-(4-((1-imino-c-beta-D-thiogalactosyl+ ++-ethyl)amino) butyl)formamide (Gal-C4-Chol) and its ethyl formamide and hexyl formamide analogues (Gal-C2-Chol, Gal-C6-Chol), to prepare liposomal gene carriers possessing the cationic charge necessary for plasmid DNA binding and galactose residues as a targetable ligand for liver parenchymal cells. Liposome/DNA complexes prepared with these lipids showed low cytotoxicity in human hepatoma HepG2 cells. Gal-C4-Chol/DC-Chol/DOPE(3:3:4) liposomes, consisting of 3:3:4 mixtures of Gal-C4-Chol, 3beta[N',N', N'-dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol), and dioleoylphosphatidylethanolamine (DOPE), showed higher transfection activity and [32P]DNA uptake than DC-Chol/DOPE(6:4) liposomes. The presence of 20 mM galactose significantly inhibited both transfection efficiency and uptake of DNA of Gal-C4-Chol/DC-Chol/DOPE(3:3:4) and Gal-C4-Chol/DOPE(6:4) liposomes, but not those of DC-Chol/DOPE(6:4) liposomes. These results indicate that the liposome/DNA complexes prepared using novel galactosylated cholesterol derivatives are efficiently recognized by asialoglycoprotein receptors and internalized and lead to gene expression. In addition, we found that the galactosylated cholesterol derivative with a longer spacer showed higher transfection activity. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813149     DOI: 10.1006/bbrc.1998.9602

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line.

Authors:  Swati A Guhagarkar; Sharmila B Majee; Abdul Samad; Padma V Devarajan
Journal:  Cancer Nanotechnol       Date:  2011-01-27

2.  Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.

Authors:  Mingzhen Zhang; Xiaoyu Wang; Moon Kwon Han; James F Collins; Didier Merlin
Journal:  Nanomedicine (Lond)       Date:  2017-06-30       Impact factor: 5.307

3.  In vivo gene delivery to the liver using novel galactosylated cationic liposomes.

Authors:  S Kawakami; S Fumoto; M Nishikawa; F Yamashita; M Hashida
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

4.  Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes.

Authors:  Sheng-Jun Mao; Shi-Xiang Hou; Ru He; Liang-Ke Zhang; Da-Peng Wei; Yue-Qi Bi; Hui Jin
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

5.  Stability of lyophilized siRNA nanosome formulations.

Authors:  Anup K Kundu; Partha K Chandra; Sidhartha Hazari; Grace Ledet; Yashoda V Pramar; Srikanta Dash; Tarun K Mandal
Journal:  Int J Pharm       Date:  2011-12-06       Impact factor: 5.875

6.  Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver.

Authors:  Shintaro Fumoto; Fumi Nakadori; Shigeru Kawakami; Makiya Nishikawa; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

Review 7.  Nano-vectors for efficient liver specific gene transfer.

Authors:  Atul Pathak; Suresh P Vyas; Kailash C Gupta
Journal:  Int J Nanomedicine       Date:  2008

8.  Preparation and property analysis of a hepatocyte targeting pH-sensitive liposome.

Authors:  Si-Yuan Wen; Xiao-Hong Wang; Li Lin; Wei Guan; Sheng-Qi Wang
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

9.  Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition.

Authors:  Aki Murao; Makiya Nishikawa; Chittima Managit; Joseph Wong; Shigeru Kawakami; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

10.  Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.

Authors:  Emi Ishida; Chittima Managit; Shigeru Kawakami; Makiya Nishikawa; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.